In this sense, it has been demonstrated that melatonin upregulates (i) E-cadherins in breast cancer and metastatic cancer [159,160], (ii) occludins in the A549 lung adenocarcinoma cell line [161], and (iii) integrins in glioma and breast cancer cells [162]. This evidence concerns the gene CDH1 and breast cancer.